Molecular and cellular mechanisms in the viral exacerbation of asthma

Microbes and Infection

Volumn 10, Issue 9, 2008, Pages 1014-1023

  Tauro, Sharyn ^a   Su, Yung Chang ^a   Thomas, Sandra ^a   Schwarze, Jürgen ^b   Matthaei, Klaus I ^c   Townsend, Dijana ^a,c   Simson, Ljubov ^a   Tripp, Ralph A ^d   Mahalingam, Suresh ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Biology and Environment   (Australia)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

Asthma; Cellular mechanism; Molecular mechanism; Pulmonary inflammation; Viral aetiology

Indexed keywords

ACETYLCHOLINE; ALLERGEN; ANTIVIRUS AGENT; CHEMOKINE; CYTOKINE; EPITOPE; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN; VIRUS ANTIGEN; VIRUS VACCINE;

ACETYLCHOLINE RELEASE; ADENOVIRUS; AGE; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; B LYMPHOCYTE; CELL ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EOSINOPHIL; EXPERIMENTAL ANIMAL; EXPERIMENTAL STUDY; FIBROBLAST; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HISTAMINE RELEASE; HOST; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA VIRUS; MACROPHAGE; MAST CELL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVE TRACT; NEUTROPHIL; NONHUMAN; PARAINFLUENZA VIRUS; PERSISTENT VIRUS INFECTION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION; VIRAL GENETICS; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS LATENCY; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEURAL PATHWAYS; PNEUMONIA; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; VIRUS LATENCY;

ANIMALIA;

EID: 53549095955     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.07.037     Document Type: Article

References (75)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhino conjunctivitis and atopic eczema. Lancet 351 (1998) 1225-1232
2. Australian Bureau of Statistics (ABS). National Health Survey: Summary of Results (2004-2005) 1-92
3. Asthma in Australia: Australian centre for asthma monitoring. Asthma series 2 (2005), Woolcock Institute of Medical Research/Australian Institute of Health and Welfare Cat. No. ACM 6
4. Data Fact Sheet: Asthma Statistics (1999), National Institutes of Health: National Heart, Lung, and Blood Institute 1-4
5. Johnston S., Pattemore P., Sanderson G., Smith S., Lampe F., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 (1995) 1225-1229
6. Schwarze J., and Gelfand E.W. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur. Respir. J. 19 (2002) 341-349
7. Culley F., Pollot J., and Openshaw P. Age at first viral infection determines the pattern of T- cell mediated disease during reinfect ion in adulthood. J. Exp. Med. 196 (2002) 1381-1386
8. Landau L. Paediatric basis of adult lung disease. Paediatr. Respir. Rev. 7 (2006) S251-S254
9. Sigurs N., Gustafsson P., Bjarnason R., Lundgberg F., and Schmidt S. Severe Respiratory Syncytial Virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171 (2005) 137-141
10. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B., and Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus: a prospective cohort study with matched controls. Pediatrics 95 (1995) 500-505
11. Johnston N.W., and Sears M.R. Asthma exacerbations 1: Epidemiology. Thorax 61 (2006) 722-728
12. Duffy D.L., Martin N.G., Battistutta D., Hopper J.L., and Mathews J.D. Genetics of asthma and hay fever in Australian twins. Am. Rev. Respir. Dis. 142 (1990) 1351-1358
13. Hoffjan S., Nicolae D., and Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir. Res. 4 (2003) 14-26
14. Puthothu B., Krueger M., Heinze J., Forster J., and Heinzmann A. Impact of IL-8 and IL-8-Receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin. Mol. Allergy. 4 (2006) 2
15. Barnes K.C., Grant A., Gao P., Baltadjieva D., Berg T., Chi P., Zhang S., Zambelli-Weiner A., Ehrlich E., Zardkoohi O., Brummet M.E., Stockton M., Watkins T., Gao L., Gittens M., Wills-Karp M., Cheadle C., Beck L.A., Beaty T.H., Becker K.G., Garcia J.G., and Mathias R.A. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J. Allergy Clin. Immunol. 118 (2006) 70-77
16. Lofgren J., Ramet M., Renko M., Marttila R., and Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial infection in infants. J. Infect. Dis. 185 (2002) 283-289
17. Hacking D., Knight J., Rocket K., Brown H., Frampton J., Kwiatkowski D.P., Hull J., and Udalova I.A. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease- susceptibility. Genes Immun 5 (2004) 274-282
18. Choi E., Lee H., Yoo T., and Chanock S. A common haplotype of interleukin 4 gene IL-4 is associated with severe respiratory syncytial virus disease in Korean children. J. Infect. Dis. 186 (2002) 1207-1211
19. Hoebee B., Rietveld E., Bont L., van Oosten M., Hodemaekers H., Nagelkerke N.J., Neijens H.J., Kimpen J.L., and Kimman T.G. Influence of promoter variants of IL-10, IL-9 and tumour necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J. Infect. Dis. 189 (2004) 239-247
20. Tal G., Mandelberg A., and Dalal I. Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189 (2004) 2057-2063
21. Puthothu B., Krueger M., Forster J., and Heinzmann A. Association between severe respiratory syncytial virus infection and IL-13/IL-4 haplotypes. J. Infect. Dis. 193 (2006) 438-441
22. Alvarez R., Harrod K., Shieh W., Zaki S., and Tripp R. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78 (2004) 14003-14011
23. Schwarze J., O'Donnell D., Rohwedder A., and Openshaw P. Latency and persistence of Respiratory Syncytial Virus despite T cell immunity. Am. J. Respir. Crit. Care Med. 169 (2004) 801-805
24. Riedel F., Oberdieck B., Streckert H., Philippou S., Krusat T., and Marek W. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea pigs. Eur. Respir. J. 10 (1997) 639-645
25. Wilkinson T., Donaldson G., Johnston S., Openshaw P., and Wedzicha J. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173 (2006) 871-876
26. Falsey A., Formica M., Hennessey P., Criddle M., Sullender W., and Walsh E.E. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173 (2006) 639-643
27. Ferreiraa A., Williamsa Z., Donningera H., van Schalkwyka E., and Bardin P.G. Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12 respiration. Respiration 69 (2002) 136-142
28. Kling S., Donninger H., Williams Z., Vermeulen J., Weinberg E., Latiff K., Ghildyal R., and Bardin P. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin. Exp. Allergy. 35 (2005) 672-678
29. Li X., Fu Z., Alvarez R., Henderson C., and Tripp R. Respiratory syncytial virus infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J. Virol. 80 (2006) 537-540
30. Alvarez R., and Tripp R.A. The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J. Virol. 79 (2005) 5971-5978
31. Mahalingam S., Schwarze J., Zaid A., Nissen M., Sloots T., Tauro S., Storer J., Alvarez R., and Tripp R.A. Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?. Microbes Infect 8 (2006) 285-293
32. Buckner C., Songsiridej V., Dick E., and Busse W. In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am. Rev. Respir. Dis. 132 (1985) 305-310
33. Empey D.W., Laitinen L.A., Jacobs L., Gold W.M., and Nadel J.A. Mechanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection. Am. Rev. Respir. Dis. 113 (1976) 523-527
34. Sorkness R., Clough J.J., Castleman W., and Lemanske R. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am. J. Respir. Crit. Care Med. 150 (1994) 28-34
35. Jacoby D.B. Virus-induced asthma attacks. J. Aerosol Med. 17 (2004) 169-173
36. Fryer A., and Jacoby D. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig. Br. J. Pharmacol. 102 (1991) 267-271
37. Fryer A., and Jacoby D. Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J. Clin. Invest. 90 (1992) 2292-2298
38. Evans C.M., Fryer A.D., Jacoby D.B., Gleich G., and Costello R. Pre-treatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal Ms muscarinic receptor function. J. Clin. Invest. 100 (1997) 2254-2262
39. Lee A.M., Fryer A.D., van Rooijen N., and Jacoby D.B. Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 286 (2004) 1255-1259
40. Bellibas S.E. The effect of human calcitonin gene-related peptide on eosinophil chemotaxis in the rat airway. Peptides 17 (1996) 563-564
41. Braunstein G., Fajac I., Lacronique J., and Frossard N. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am. Rev. Respir. Dis. 144 (1991) 630-635
42. Heaney L.G., Cross L.J., Stanford C.F., and Ennis M. Substance, P induces histamine release from human pulmonary mast cells. Clin. Exp. Allergy. 25 (1995) 179-186
43. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., and Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5 (1998) 9-15
44. Hu C., Wedde-Beer K., Auais A., Rodriguez M., and Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002) 494-502
45. Piedimonte G., Rodriguez M., King K., McLean S., and Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 277 (1999) 831-840
46. Nassenstein C., Schulte-Herbruggen O., Renz H., and Braun A. Nerve growth factor: The central hub in the development of allergic asthma?. Eur. J. Pharmacol. 533 (2006) 195-206
47. Schwarze J., Cieslewicz G., Hamelmann E., Joetham A., Schultz L.D., Lamers M.C., and Gelfand E.W. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J. Immunol. 162 (1999) 2997-3004
48. Tekkanat K.K., Maassab H.F., Cho D.S., Lai J.J., John A., Berlin A., Kaplan M.H., and Lukacs N.W. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J. Immunol. 166 (2001) 3542-3548
49. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Hamelmann E., and Gelfand E.W. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162 (1999) 4207-4211
50. Brimnes M.K., Bonifaz L., Steinman R.M., and Moran T.M. Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic Protein. J. Exp. Med. 198 (2003) 133-144
51. Wang H., Peters N., Laza-Stanca V., Nawroly N., Johnston S.L., and Schwarze J. Local CD11c+ MHC II precursors give rise to pulmonary myeloid dendritic cells and are depleted in the process after RSV infection. J. Immunol. 177 (2006) 2536-2542
52. Constant S.L., Brogdon J.L., Piggott D.A., Herrick C.A., Visintin I., Ruddle N.H., and Bottomly K. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110 (2002) 1441-1448
53. Robinson P., Hegele R., and Schellenberg R. Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. Clin. Immunol. 100 (1997) 492-498
54. Makela M., Tripp R., and Dakama A. Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. J. Allergy Clin. Immunol. 112 (2003) 861-869
55. Wu C., Puddington L., Whiteley H., Yiamouyiannis C., Schramm C., Mohammadu F., and Thrall R.S. Murine Cytomegalovirus infection alters Th1/Th2 cytokine expression, decreases airway eosinophilia and enhances mucus production in allergic airway disease. J. Immunol. 167 (2001) 2798-2807
56. Matsuse H., Behera A., Kumar M., and Rabb H. Recurrent respiratory syncytial virus infections in allergen sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J. Immunol. 164 (2000) 6583-6592
57. Barends M., Van Oosten M., De Rond C.G., Dormans J.A., and Osterhaus A.D. Timing of infection and prior immunization with respiratory syncytial virus in RSV-enhanced allergic inflammation. J. Infect. Dis. 189 (2004) 1866-1872
58. Mäkelä M.J., Kanehiro A., Borish L., Dakhama A., Loader J., Joetham A., Xing Z., Jordana M., Larsen G.L., and Gelfand E.W. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6007-6012
59. Makela M., Kanehiro A., and Borish L. The failure of IL-10 deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen sensitized/challenged mice. Am. J. Respir. Crit. Care Med. 165 (2002) 824-831
60. Won Park J., Taube C., Yang E., and Joetham A. Respiratory syncytial virus induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. J. Allergy Clin. Immunol. 112 (2003) 1078-1087
61. Kanaoka Y., and Boyce J. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173 (2004) 1503-1510
62. Volovitz B., Welliver R., De Castro G., Krystofik D., and Ogra P. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24 (1988) 504-507
63. Drazen J.M., O'Brien J., Sparrow D., Weiss S.T., Martins M.A., Israel E., and Fanta C.H. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am. Rev. Respir. Dis. 146 (1992) 104-108
64. Kim C.K., Koh J.Y., Han T.H., Kim do K., Kim B.I., and Koh Y.Y. Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis. Acta Pediatr 95 (2006) 479-485
65. Fullmer J.J., Khan A.M., Elidemir O., Chiappetta C., Stark J.M., and Colasurdo G.N. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice. Pediatr. Allergy Immunol. 16 (2005) 593-601
66. Welliver II R.C., Hintz K.H., Glori M., and Welliver Sr. R.C. Zileuton reduces respiratory illness and lung inflammation, during respiratory syncytial virus infection, in mice. J. Infect. Dis. 187 (2003) 1773-1779
67. Bisgaard H. Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am. J. Respir. Crit. Care Med. 167 (2003) 379-383
68. Laitinen L., and Kava T. Bronchial reactivity following uncomplicated influenza A infection in healthy subjects and in asthmatic patients. Eur. J. Respir. Dis. 106 Suppl (1980) 51-58
69. Fleming E., Little F., Schnurr D., Avila P., Wong H., Liu J., Yagi S., and Boushey H.A. Rhinovirus-16 colds in healthy and in asthmatic subjects. Similar changes in upper and lower airways. Am. J. Crit. Care Med. 160 (1999) 100-108
70. Lemanske R., Dick E., Swenson C., Vrtis R., and Busse W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 83 (1989) 1-10
71. Zambrano J., Carper H., Rakes G., Patrie J., Murphy D., Platts-Mills T.A., Hayden F., Gwaltney J., Hatley T.K., Owens A.M., and Heymann P. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J. Allergy Clin. Immunol. 111 (2003) 1008-1016
72. Calhoun W., Swenson C., Dick E., Schwartz L., Lemanske R., and Busse W. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 144 (1991) 1267-1273
73. Calhoun W., Dick E., Schwartz L., and Busse W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J. Clin. Invest. 94 (1994) 2200-2208
74. Papadopoulos N., Stanciu L., Papi A., Holgate S., and Johnston S. A defective Type 1 response to rhinovirus in atopic asthma. Thorax 57 (2002) 328-332
75. Mahalingam S., Herd K., Mackay I.M., Nissen M., Sloots T.P., and Tindle R.W. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J. Virol. 80 (2006) 2034-2044